Report Detail
Global (United States, European Union and China) Herpes Labialis Treatment Market Research Report 2019-2025
- RnM3681931 |
- 19 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Herpes labialis, also known as cold sores, is a type of infection by the herpes simplex virus that affects primarily the lip. Symptoms typically include a burning pain followed by small blisters or sores. The first attack may also be accompanied by fever, sore throat, and enlarged lymph nodes. The rash usually heals within 10 days, but the virus remains dormant in the facial nerve. The virus may periodically reactivate to create another outbreak of sores in the mouth or lip.
With over 35% value share, North America stood the top market for herpes labialis treatment in 2017. This region is expected to continue its dominance through the forecast period, followed by Western Europe, which recorded over 20% share of the total market value in 2017.
In 2019, the market size of Herpes Labialis Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Herpes Labialis Treatment.
This report studies the global market size of Herpes Labialis Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Herpes Labialis Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Teva
Abbott
Sun
Mylan
Pfizer
GlaxoSmithKline
Dr. Reddy's
Novartis
Market Segment by Product Type
Acyclovir
Valacyclovir
Famciclovir
Penciclovir
Docosanol
Market Segment by Application
Topical
Oral
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Herpes Labialis Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Herpes Labialis Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Herpes Labialis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Herpes Labialis Treatment Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Acyclovir
- 1.3.3 Valacyclovir
- 1.3.4 Famciclovir
- 1.3.5 Penciclovir
- 1.3.6 Docosanol
- 1.4 Market Segment by Application
- 1.4.1 Global Herpes Labialis Treatment Market Share by Application (2019-2025)
- 1.4.2 Topical
- 1.4.3 Oral
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Herpes Labialis Treatment Market Size
- 2.1.1 Global Herpes Labialis Treatment Revenue 2014-2025
- 2.1.2 Global Herpes Labialis Treatment Sales 2014-2025
- 2.2 Herpes Labialis Treatment Growth Rate by Regions
- 2.2.1 Global Herpes Labialis Treatment Sales by Regions 2014-2019
- 2.2.2 Global Herpes Labialis Treatment Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Herpes Labialis Treatment Sales by Manufacturers
- 3.1.1 Herpes Labialis Treatment Sales by Manufacturers 2014-2019
- 3.1.2 Herpes Labialis Treatment Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Herpes Labialis Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Herpes Labialis Treatment Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Herpes Labialis Treatment Market Concentration Ratio (CR5 and HHI)
- 3.3 Herpes Labialis Treatment Price by Manufacturers
- 3.4 Key Manufacturers Herpes Labialis Treatment Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Herpes Labialis Treatment Market
- 3.6 Key Manufacturers Herpes Labialis Treatment Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Acyclovir Sales and Revenue (2014-2019)
- 4.1.2 Valacyclovir Sales and Revenue (2014-2019)
- 4.1.3 Famciclovir Sales and Revenue (2014-2019)
- 4.1.4 Penciclovir Sales and Revenue (2014-2019)
- 4.1.5 Docosanol Sales and Revenue (2014-2019)
- 4.2 Global Herpes Labialis Treatment Sales Market Share by Type
- 4.3 Global Herpes Labialis Treatment Revenue Market Share by Type
- 4.4 Herpes Labialis Treatment Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Herpes Labialis Treatment Sales by Application
6 United States
- 6.1 United States Herpes Labialis Treatment Breakdown Data by Company
- 6.2 United States Herpes Labialis Treatment Breakdown Data by Type
- 6.3 United States Herpes Labialis Treatment Breakdown Data by Application
7 European Union
- 7.1 European Union Herpes Labialis Treatment Breakdown Data by Company
- 7.2 European Union Herpes Labialis Treatment Breakdown Data by Type
- 7.3 European Union Herpes Labialis Treatment Breakdown Data by Application
8 China
- 8.1 China Herpes Labialis Treatment Breakdown Data by Company
- 8.2 China Herpes Labialis Treatment Breakdown Data by Type
- 8.3 China Herpes Labialis Treatment Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Herpes Labialis Treatment Breakdown Data by Company
- 9.2 Rest of World Herpes Labialis Treatment Breakdown Data by Type
- 9.3 Rest of World Herpes Labialis Treatment Breakdown Data by Application
- 9.4 Rest of World Herpes Labialis Treatment Breakdown Data by Countries
- 9.4.1 Rest of World Herpes Labialis Treatment Sales by Countries
- 9.4.2 Rest of World Herpes Labialis Treatment Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Teva
- 10.1.1 Teva Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Herpes Labialis Treatment
- 10.1.4 Herpes Labialis Treatment Product Introduction
- 10.1.5 Teva Recent Development
- 10.2 Abbott
- 10.2.1 Abbott Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Herpes Labialis Treatment
- 10.2.4 Herpes Labialis Treatment Product Introduction
- 10.2.5 Abbott Recent Development
- 10.3 Sun
- 10.3.1 Sun Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Herpes Labialis Treatment
- 10.3.4 Herpes Labialis Treatment Product Introduction
- 10.3.5 Sun Recent Development
- 10.4 Mylan
- 10.4.1 Mylan Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Herpes Labialis Treatment
- 10.4.4 Herpes Labialis Treatment Product Introduction
- 10.4.5 Mylan Recent Development
- 10.5 Pfizer
- 10.5.1 Pfizer Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Herpes Labialis Treatment
- 10.5.4 Herpes Labialis Treatment Product Introduction
- 10.5.5 Pfizer Recent Development
- 10.6 GlaxoSmithKline
- 10.6.1 GlaxoSmithKline Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Herpes Labialis Treatment
- 10.6.4 Herpes Labialis Treatment Product Introduction
- 10.6.5 GlaxoSmithKline Recent Development
- 10.7 Dr. Reddy's
- 10.7.1 Dr. Reddy's Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Herpes Labialis Treatment
- 10.7.4 Herpes Labialis Treatment Product Introduction
- 10.7.5 Dr. Reddy's Recent Development
- 10.8 Novartis
- 10.8.1 Novartis Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Herpes Labialis Treatment
- 10.8.4 Herpes Labialis Treatment Product Introduction
- 10.8.5 Novartis Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Herpes Labialis Treatment Sales Channels
- 11.2.2 Herpes Labialis Treatment Distributors
- 11.3 Herpes Labialis Treatment Customers
12 Market Forecast
- 12.1 Global Herpes Labialis Treatment Sales and Revenue Forecast 2019-2025
- 12.2 Global Herpes Labialis Treatment Sales Forecast by Type
- 12.3 Global Herpes Labialis Treatment Sales Forecast by Application
- 12.4 Herpes Labialis Treatment Forecast by Regions
- 12.4.1 Global Herpes Labialis Treatment Sales Forecast by Regions 2019-2025
- 12.4.2 Global Herpes Labialis Treatment Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Herpes Labialis Treatment. Industry analysis & Market Report on Herpes Labialis Treatment is a syndicated market report, published as Global (United States, European Union and China) Herpes Labialis Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Herpes Labialis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
